Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Drug Use Investigation Of Azithromycin Iv.

Trial Profile

Drug Use Investigation Of Azithromycin Iv.

Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs Azithromycin (Primary) ; Azithromycin (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia; Pelvic inflammatory disorders
  • Focus Adverse reactions
  • Acronyms RESCUE
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 08 Feb 2016 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 Feb 2016 Planned End Date changed from 1 Nov 2015 to 1 May 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top